期刊文献+

DP化疗方案治疗晚期三阴性乳腺癌的效果观察

在线阅读 下载PDF
导出
摘要 目的分析DP化疗方案治疗晚期三阴性乳腺癌(TNBC)的效果。方法选取河南科技大学第二附属医院2015年3月至2017年3月收治的58例晚期TNBC患者。依照治疗方案分为观察组(DP化疗方案)和对照组(GP化疗方案),各29例。比较两组临床疗效、治疗前后疼痛视觉模拟评分法(VAS)及生活质量评估量表(QQL)评分和毒副反应发生率。结果观察组治疗总有效率(75.86%)高于对照组(48.28%),QQL评分[(51.18±5.36)分]高于对照组[(43.78±5.37)分],VAS评分[(2.12±0.45)分]低于对照组[(3.18±0.74)分],毒副反应发生率(65.51%)低于对照组(89.66%),差异有统计学意义(P<0.05)。结论 DP化疗方案治疗TNBC效果显著,能减轻患者疼痛,降低毒副反应发生率,提高生活质量,值得临床推广应用。
作者 贠春燕
出处 《河南医学研究》 CAS 2018年第10期1844-1845,共2页 Henan Medical Research
  • 相关文献

参考文献5

二级参考文献69

  • 1孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,1998.45.
  • 2Lin Y, Lin S, Watson M, et al. A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy[ J]. Breast Cancer Res Treat, 2010, 123(3) :691 -699.
  • 3Rastogi P, Anderson S J, Bear HD, et al. Preoperative chemother- apy : updates of National Surgical Adjuvant Breast and Bowel Pro- ject Protocols B-18 and B-27 [ J ]. J Clin Oncol,2008,26 (5) : 778 - 785.
  • 4Liedtke C, Mazouni C, Hess KR,et al. Response to neoadjuvant- therapy and long-term survival in patients with triple-negative breast cancer [ J ]. J Clin Oncol,2008,26 ( 8 ) : 1275 - 1281.
  • 5Yi S, Uhm J, Cho E, et al. Clinical outcomes of metastatic breast cancer patients with triple-negative phenotype who received platinum-containing chemotherapy [ J ]. J Clin Oncol, 2008,26 (15) :a1008.
  • 6Noh JM, Choi DH, Back H, et al. Associations between BRCA mutations in high-risk breast cancer patients and familial cancer other than breast or ovary [ J ]. J Breast Cancer,2012,15 (3) : 283 - 287.
  • 7Bertucci F, Finetti P, Cervera N, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast canc- ers[J]. Cancer Res,2006,66(9) :4636 -4644.
  • 8Von Minckwitz G, Martin M. Neoadjuvant treatments for triple- negative breast cancer( TNBC ) [J]. Ann Onco1,2012,23 (Suppl 6) : 35 -39.
  • 9Shien T, Akashi-Tanaka S, Miyakawa K, et al. Clinicopathological features of tumors as predictors of the efficacy of primary neoadju- rant chemotherapy for operable breast cancer [ J ]. World J Surg, 2009,33(1) : 44 -51.
  • 10Futakuchi M,Singh RK.Animal model for mammary tumor growth in the bone microenvironment[J].Breast Cancer,2013,13:439-445.

共引文献264

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部